Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
26.59
-0.29 (-1.08%)
At close: Feb 11, 2026, 4:00 PM EST
26.05
-0.54 (-2.04%)
After-hours: Feb 11, 2026, 6:41 PM EST
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.26 billion as of February 11, 2026. Its market cap has increased by 95.28% in one year.
Market Cap
3.26B
Enterprise Value
3.18B
1-Year Change
95.28%
Ranking
Category
Stock Price
$26.59
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.26B, an increase of 316.48%. That is a compound annual growth rate of 26.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.29B | -7.44% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 3.68B |
| Liquidia | 3.53B |
| Centessa Pharmaceuticals | 3.44B |
| Alumis | 3.31B |
| Legend Biotech | 3.31B |
| Xenon Pharmaceuticals | 3.30B |
| Edgewise Therapeutics | 3.28B |
| Viking Therapeutics | 3.25B |